Epidemiology of meningitis and bacteraemia due to Streptococcus pneumoniae in the Netherlands

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 89, Issue 435, 2000, Pages 22-26

  Spanjaard, L ^a   van der Ende, A ^a   Rumke H ^b   Dankert, J ^a   van Alphen, L ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Bacteraemia; Meningitis; Penicillin susceptibility; Predisposing factors; Serotypes; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CHILD; CHILDHOOD DISEASE; DISEASE PREDISPOSITION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; NETHERLANDS; PENICILLIN RESISTANCE; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0034501368     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2000.tb00778.x     Document Type: Article

References (13)

1. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: High efficacy and lack of herd immunity
2. Epidemiology of bacterial meningitis in the Netherlands, part II. Thesis
3. Is de incidentie van sepsis en meningitis door Streptococcus pneumoniae in Nederland toegenomen?
4. Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992
5. Increase in pneumococcal bacteraemia in Sweden
6. Temporary increase in incidence of invasive infection due to Streptococcus pneumoniae in the Netherlands
7. Gezondheidsraad
8. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
9. Which pneumococcal serogroups cause most invasive disease: Implications for conjugate vaccine formulation and use. Part I
10. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
11. Penicillin-resistant Streptococcus pneumoniae in the Netherlands: Results of a 1-year molecular epidemiological survey
12. Molecular epidemiology of drug-resistant pneumococci: Toward an international approach